- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hormone-resistant Prostate Cancer in United States
Total 7273 results
-
Temple UniversityCompleted
-
NGM Biopharmaceuticals, IncActive, not recruitingMelanoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Metastatic Castration-resistant Prostate Cancer | Head Neck Squamous Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Testosterone Greater Than 150 ng/dLUnited States
-
Georgetown UniversityU.S. Army Medical Research and Development CommandCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Stage IV Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterProgenics Pharmaceuticals, Inc.Active, not recruitingProstate Cancer | Metastatic Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Prostate NeoplasmUnited States
-
Mayo ClinicNot yet recruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Localized Prostate AdenocarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterRecruitingProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer American Joint Committee on...United States
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterCompletedStage II Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Praful Ravi, MB BCHir, MRCPEli Lilly and Company; BayerActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Non-metastatic Prostate CancerUnited States
-
Accuray IncorporatedCompletedProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
St. Louis UniversityWithdrawn
-
Massachusetts General HospitalCompletedLung Cancer | Solid Tumor (Not Breast or Prostate Cancers)United States
-
Veterans Medical Research FoundationUniversity of California, San Diego; Alliant International UniversityCompleted
-
Won KimNovartisTerminated
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy
-
zr Pharma & GmbHFoundation MedicineCompletedMetastatic Castration Resistant Prostate CancerUnited States, Spain, United Kingdom, France, Australia, Belgium, Denmark, Israel, Germany, Ireland, Canada, Italy
-
NanOlogy, LLCUS Biotest, Inc.TerminatedUrogenital Neoplasms | Genital Neoplasms, Male | Prostate Cancer | Prostate Adenocarcinoma | Prostatic Neoplasm | Localized Cancer | Prostate Cancer AdenocarcinomaUnited States
-
Corvus Pharmaceuticals, Inc.Genentech, Inc.CompletedRenal Cell Cancer | Metastatic Castration Resistant Prostate CancerUnited States, Canada, Australia
-
Accuray IncorporatedCompletedProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Nottingham University Hospitals NHS Trust; Barts & The London NHS Trust and other collaboratorsRecruitingHormone Refractory Prostate CancerUnited Kingdom
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | PSA Progression | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
Ohio State University Comprehensive Cancer CenterPfizer; Myovant Sciences GmbH; Sumitomo Pharmaceuticals AmericaNot yet recruitingProstate Adenocarcinoma | Stage IIC Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
Mamta ParikhNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Advanced Prostate AdenocarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingProstate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8United States
-
Thomas Jefferson UniversitySuspendedProstate Adenocarcinoma | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
Rahul AggarwalMerck Sharp & Dohme LLC; U.S. Army Medical Research and Development Command; Zenith...RecruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Metastatic Prostate Small Cell CarcinomaUnited States
-
Matrix Biomed, Inc.Prostate Oncology SpecialistsNot yet recruitingProstate Cancer Recurrent | Biochemical Recurrent Prostate CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI); AstraZenecaCompletedCastration-Resistant Prostate Carcinoma | Prostate AdenocarcinomaUnited States
-
Duke UniversityExelixisTerminatedProstate Cancer | Prostate Cancer Adenocarcinoma | Non-MetastaticUnited States
-
Arno TherapeuticsUnknownRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Androgen-independent Prostate CancerUnited Kingdom
-
Henry Ford Health SystemAmerican Cancer Society, Inc.WithdrawnLow or Intermediate Risk Prostate CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
GenesisCare USADendreonCompletedCastrate Refractory Metastatic Prostate Cancer (mCRPC)United States
-
University of Colorado, DenverActive, not recruitingRecurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
BayerCompletedBone Metastases | Castration-Resistant Prostate CancerUnited States, France
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of HawaiiGenentech, Inc.; DendreonCompletedProstate Cancer MetastaticUnited States
-
SCRI Development Innovations, LLCNovartisWithdrawnAdvanced Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
University of Kansas Medical CenterNational Cancer Institute (NCI)Not yet recruitingRelugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate CancerStage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8United States
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingProstatic Neoplasms, Castration-Resistant | Prostatic Cancer, Castration-Resistant | Castration Resistant Prostatic Neoplasms | Androgen-Resistant Prostatic NeoplasmsUnited States, Canada
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate... and other conditionsUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Oregon Health and Science UniversityCompletedProstate Cancer | Metastatic, Androgen Independent Prostate CancerUnited States
-
Emory UniversityNational Cancer Institute (NCI)Active, not recruitingBiochemically Recurrent Prostate Carcinoma | Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC... and other conditionsUnited States
-
Jonsson Comprehensive Cancer CenterCompletedBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | PSA Level Greater Than FiftyUnited States